A 10-year Taiwanese cohort by Yang et al. found that ALT levels and HCC risk were significantly higher in HBV/HCV coinfection compared to HBV monoinfection [27], highlighting the need for close monitoring in this high-risk population [6]. The gene discussed is GPT; the disease is hepatocellular carcinoma.